Previous 10 | Next 10 |
TC BioPharm Announces $7.35 Million Private Placement PR Newswire EDINBURGH, Scotland , Nov. 28, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company d...
TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia PR Newswire 3 Patients Dosed in 5 Patient Safety Cohort EDINBURGH, Scotland , Nov. 22, 2022 /PRNewswire/ -...
TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise PR Newswire SAB selected to advance new therapeutic trials and strategic partnerships EDINBURGH, Scotland , Oct. 26, 2022 /PRNewswire/ -- TC Bi...
TC BioPharm to Present at Upcoming Investor Conferences PR Newswire EDINBURGH, Scotland , Oct. 3, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company devel...
TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune® PR Newswire EDINBURGH, Scotland , Sept. 13, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDA...
TC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland , Aug. 22, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical s...
TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit PR Newswire Event Taking Place in Boston on July 26-28, 2022 EDINBURGH, Scotland , July 25, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Co...
TC BioPharm CEO, Bryan Kobel to Speak at the "Innovating Cell and Gene Therapy Quality Control Conference 2022" PR Newswire Management will Participate in Fireside Chat on TC BioPharm's Journey as a Successful CGT Startup on July 13, 2022 EDINBURGH, Scotl...
TC Biopharm Announces Closing of $4 Million Underwritten Public Offering PR Newswire EDINBURGH, Scotland , June 7, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnol...
TC BioPharm (NASDAQ:TCBP) stock fell ~36% premarket June 3 after the company priced a public offering of 10M American Depositary Shares (ADSs) at $0.40 per ADS for gross proceeds of $4M. The company announcement came in a post-market June 2 release. Each ADS represents one ordinary ...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
TCBP Adjourns General Meeting Until a Later Date PR Newswire EDINBURGH, Scotland , March 19, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...
Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financ...
TCBP Announces Exercise of Series D Warrants For Cash PR Newswire • Company receives gross proceeds of $1.26 M from transaction EDINBURGH, Scotland , March 18, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (...